Bioventus Inc.BVSNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$39.22M
↑ 71% above average
Average (9y)
$22.95M
Historical baseline
Range
High:$61.58M
Low:$-121.61M
CAGR
+11.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $39.22M | +270.0% |
| 2023 | $-23.07M | +81.0% |
| 2022 | $-121.61M | -367.4% |
| 2021 | $45.48M | -16.3% |
| 2020 | $54.31M | -11.8% |
| 2019 | $61.58M | +13.0% |
| 2018 | $54.52M | -8.9% |
| 2017 | $59.85M | +35.9% |
| 2016 | $44.05M | +190.1% |
| 2015 | $15.18M | - |